Shanghai Henlius Biotech, Inc. engages in the production and sale of monoclonal antibody (mAb) drugs and the provision of related consultation and technical services, and the transfer of its own technology. The company is headquartered in Shanghai, Shanghai and currently employs 3,537 full-time employees. The company went IPO on 2019-09-25. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The firm mainly operates its businesses in the domestic and overseas markets.
02696.HK stock price ended at $71.95 on Perşembe, after rising 0.84%
On the latest trading day Feb 12, 2026, the stock price of 02696.HK rose by 0.84%, climbing from $71.40 to $71.95. Throughout the session, the stock experienced a volatility of 3.71%, with prices fluctuating between a daily low of $71.40 and a high of $74.05. Alongside this price increase, trading volume also rose by 4.7M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 793.2K shares were traded, amounting to a market value of approximately $11.7B.
02696.HKTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 3
Nötr Sinyaller 0
Satış Sinyalleri 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
02696.HK, şu anda 3 alım sinyali ve 4 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Yukarı trend durumundadır ve bu dönemde toplam 0.84% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Sell görünüm işaret etmektedir.
02696.HK için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek 02696.HK için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.